Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts

详细信息    查看全文

• 作者：Hannu-Ville Leskelä ; Anu Olkku ; Siri Lehtonen ; Anitta Mahonen ; Jussi Koivunen ; Miia Turpeinen ; Jouko Uusitalo ; Olavi Pelkonen ; Lauri Kangas ; Katri Selander and Petri Lehenkari
• 关键词：Mesenchymal stem cells ; Osteoblasts ; Estrogen receptor alpha ; Sex steroids ; Polymorphism
• 刊名：Bone
• 出版年：2006
• 出版时间：November 2006
• 年：2006
• 卷：39
• 期：5
• 页码：1026-1034
• 全文大小：660 K

文摘

Hormone replacement therapy is effectively used to prevent postmenopausal bone loss. Variation in response to the therapy is, however, frequently seen. In addition, the direct effects of sex steroids on isolated human bone marrow stromal cells have been reported to vary depending on the donor, but the biological mechanisms are not understood. The aim of this study was to investigate the effects of 17β-estradiol (E2) and testosterone in human-bone-marrow-derived mesenchymal stem cell (MSC) cultures from both female and male donors of various ages. The osteoblast differentiation capacity and activity of the MSCs were quantified in vitro by measuring alkaline phosphatase activity and calcium deposition. We show here that also the osteoblast responses of MSCs to sex hormones vary widely depending on the donor. When the results from all donors were analyzed together, treatment with E2 increased calcium deposition significantly by MSCs of both sexes but ALP activity only in the male MSCs. Testosterone had no effect on ALP activity nor calcium deposition in either sex. To further characterize the individual variation, we investigated estrogen receptor alpha PvuII restriction site polymorphism with PCR. Restriction fragment-length polymorphism was assigned as P or non-P, P signifying the absence of the restriction site. Our results indicate that higher basal osteoblast differentiation capacity of MSCs is associated with the presence of the P allele in females, whereas higher response to sex steroids treatment is associated with the non-P allele. These results could help explain the contradictory effects of E2 on osteoblasts in vitro and might also provide new insights to understanding the differences in responses to hormone replacement therapy.